expert perspectives

in Plaque Psoriasis

Expert Perspectives in Plaque Psoriasis to Cover Key Topics in Plaque Psoriasis Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Plaque Psoriasis will feature selected topics in Plaque Psoriasis that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts:

Boni E. Elewski, MD

James Elder Endowed Professor and Chair of Graduate Medical Education
Department of Dermatology
University of Alabama
Birmingham, AL

Steven R. Feldman, MD, PhD

Professor of Dermatology, Pathology, and Social Sciences & Health Policy
Wake Forest School of Medicine
Winston-Salem, NC 

Bruce E. Strober, MD, PhD

Clinical Professor, Department of Dermatology
Yale University School of Medicine
Central Connecticut Dermatology Research
Cromwell, CT

Community-Selected Topics: 

Expert Roundtables 

    What Drives the Choice Between Systemic Drugs in the Treatment of Plaque Psoriasis?
    Biologic Treatment Algorithms for Patients With Plaque Psoriasis With Comorbid Conditions/Special Populations
    Newer and Pipeline Biologics for Plaque Psoriasis
    Use of Small-Molecule Drugs for Plaque Psoriasis 


Clinical Topic Updates 

    Identifying Patients With Psoriasis at Risk for Developing Psoriatic Arthritis
    Plaque Psoriasis and Cardiovascular Disease
    Serious Infection Risk and the Use of Biologics for Plaque Psoriasis
    Switching Strategies in the Management of Plaque Psoriasis 


Patient Care Perspectives 

    Overcoming Barriers to Quality Psoriasis Care
    Plaque Psoriasis: Disease Burden and Patient Needs
    Screening for Psoriatic Arthritis and Axial Involvement: Tips for Dermatologists
    Impact of Lifestyle Changes in the Management of Plaque Psoriasis 


More in Plaque Psoriasis

Thumb

Plaque Psoriasis

Interleukin-23p19 Inhibitors: Current Perspectives

Clinical Topic Updates by Alice B. Gottlieb, MD, PhD

Selective inhibitors of the interleukin-23p19 (IL-23p19) subunit have emerged as highly effective therapies for patients with moderate to severe pl...READ MORE

Thumb

Plaque Psoriasis

TNF Inhibitor–Induced Psoriasis

Clinical Topic Updates by Steven R. Feldman, MD, PhD

Psoriasis induced by tumor necrosis factor–α inhibitor (TNFi) therapy is a relatively uncommon side effect that may occur during the treatment of p...READ MORE

Thumb

Plaque Psoriasis

Psoriasis Flare or Diminishing Response to Treatment?

Patient Care Perspectives by Steven R. Feldman, MD, PhD

In patients with psoriasis, a disease flare may result from a loss of response (eg, due to antidrug antibodies), increased disease activity, or adh...READ MORE

More In Dermatology

Plaque Psoriasis

Use Of Small Molecule Drugs For Plaque Psoriasis

Expert Roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD

Plaque Psoriasis

Newer And Pipeline Therapies And Biologics For Plaque Psoriasis

Expert Roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD

Plaque Psoriasis

Screening For Psoriatic Arthritis And Axial Involvement: Tips For Dermatologists

Patient Care Perspectives by Bruce E. Strober, MD, PhD